More than half a year into legalized recreational cannabis usage in Canada, 11 movers and shakers from the licensed market have come together to form the board of an association aimed at supporting the overall industry.
The Cannabis Council of Canada (C3) today announced its new lineup for the board of directors, featuring senior management from companies such as Organigram Holdings Inc. (TSX-V: OGI; OTCQX: OGRMF), Aphria Inc. (TSX: APHA; NYSE: APHA), Supreme Cannabis Company (TSX: FIRE), and Tilray Inc. (NASDAQ: TLRY).
Notably, Organigram’s SVP of Marketing and Communications Ray Gracewood was appointed to the board, while Aphria’s VP of marketing Megan McCrae was named chair.
The full new board lineup – which will focus on advancing legalized cannabis usage for patients and recreational consumers globally – is now as follows:
- Megan McCrae – Aphria Inc., Board Chair
- Philippe Lucas – Tilray, Vice Chair, Medical
- John Fowler – The Supreme Cannabis Company, Vice Chair, Adult Use
- Ray Gracewood – Organigram
- Darren Karasiuk – Aurora Cannabis Inc.
- Jeff Jacobson – Cronos Group
- Alison Gordon – 48 North Cannabis Co.
- Ruth Chun – Newstrike
- Jeff Ryan – Canopy Growth Corporation
- Isabelle Robillard – HEXO Corp
- Gerald Proctor – Sundial Growers
Vice Chair John Fowler commented on the leadership change within the C3 board:
Aside from providing a key member of upper management to the Cannabis Council of Canada’s board, Organigram itself recently underwent internal board of director changes. The company’s primary medical board member, Dr. Kenneth Mitton, stepped down from his position last month.
The company has seen a variety of new hires on the upper management level as well in recent months, bringing in new talent to serve as head of Human Resources as well as the newly created roles of Plant Manager and Chief Of Staff.
A full rundown of Organigram’s Q2 2019 quarterly financial results from Grizzle’s head of research can also be found by heading over here.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.